Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Mol Metab. 2021 Jun;48:101227. doi: 10.1016/j.molmet.2021.101227. Epub 2021 Mar 31.
Liver glycogen levels are dynamic and highly regulated by nutrient availability as the levels decrease during fasting and are restored during the feeding cycle. However, feeding in the presence of fructose in water suppresses glycogen accumulation in the liver by upregulating the expression of the glucose-6-phosphatase catalytic subunit (G6pc) gene, although the exact mechanism is unknown. We generated liver-specific knockout MED13 mice that lacked the transcriptional Mediator complex kinase module to examine its effect on the transcriptional activation of inducible target gene expression, such as the ChREBP- and FOXO1-dependent control of the G6pc gene promoter.
The relative changes in liver expression of lipogenic and gluconeogenic genes as well as glycogen levels were examined in response to feeding standard low-fat laboratory chow supplemented with water or water containing sucrose or fructose in control (Med13) and liver-specific MED13 knockout (MED13-LKO) mice.
Although MED13 deficiency had no significant effect on constitutive gene expression, all the dietary inducible gene transcripts were significantly reduced despite the unchanged insulin sensitivity in the MED13-LKO mice compared to that in the control mice. G6pc gene transcription displayed the most significant difference between the Med13 and MED13-LKO mice, particularly when fed fructose. Following fasting that depleted liver glycogen, feeding induced the restoration of glycogen levels except in the presence of fructose. MED13 deficiency rescued the glycogen accumulation defect in the presence of fructose. This resulted from the suppression of G6pc expression and thus G6PC enzymatic activity. Among two transcriptional factors that regulate G6pc gene expression, FOXO1 binding to the G6pc promoter was not affected, whereas ChREBP binding was dramatically reduced in MED13-LKO hepatocytes. In addition, there was a marked suppression of FOXO1 and ChREBP-β transcriptional activities in MED13-LKO hepatocytes.
Taken together, our data suggest that the kinase module of the Mediator complex is necessary for the transcriptional activation of metabolic genes such as G6pc and has an important role in regulating glycogen levels in the liver through altering transcription factor binding and activity at the G6pc promoter.
肝糖原水平是动态的,受营养物质可用性的高度调节,在禁食期间降低,在进食周期中恢复。然而,在水中摄入果糖会通过上调葡萄糖-6-磷酸酶催化亚基(G6pc)基因的表达来抑制肝糖原的积累,尽管确切的机制尚不清楚。我们生成了肝脏特异性敲除 MED13 小鼠,该小鼠缺乏转录中介体复合物激酶模块,以检查其对诱导靶基因表达的转录激活的影响,例如 ChREBP 和 FOXO1 依赖性控制 G6pc 基因启动子。
在对照(Med13)和肝脏特异性 MED13 敲除(MED13-LKO)小鼠中,检查标准低脂实验室饲料补充水或水含有蔗糖或果糖时,肝内脂质生成和糖异生基因以及糖原水平的相对变化。
尽管 MED13 缺乏对组成型基因表达没有显著影响,但所有饮食诱导的基因转录物都显著降低,尽管 MED13-LKO 小鼠的胰岛素敏感性与对照小鼠相比没有变化。G6pc 基因转录在 Med13 和 MED13-LKO 小鼠之间显示出最大的差异,特别是在喂食果糖时。在耗尽肝糖原的禁食后,进食诱导糖原水平的恢复,除了在果糖存在的情况下。MED13 缺乏症在存在果糖的情况下挽救了糖原积累缺陷。这是由于 G6pc 表达的抑制,因此 G6PC 酶活性。在调节 G6pc 基因表达的两个转录因子中,FOXO1 与 G6pc 启动子的结合不受影响,而 ChREBP 结合在 MED13-LKO 肝细胞中显著降低。此外,在 MED13-LKO 肝细胞中,FOXO1 和 ChREBP-β转录活性明显受到抑制。
总之,我们的数据表明,中介体复合物的激酶模块对于 G6pc 等代谢基因的转录激活是必要的,并通过改变 G6pc 启动子处转录因子结合和活性在调节肝脏糖原水平方面发挥重要作用。